iShares U.S. Pharmaceuticals ETF
Limited financial coverage for IHE.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The iShares U. S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index.
- IPO
- 2006
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on IHE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.18B
- Div Yield
- 1.38%
- 52W High
- $112.29
- 52W Low
- $81.45
- 50D MA
- $103.46
- 200D MA
- $96.26
- Beta
- 0.52
- RSI (14)
- 44
- Avg Volume
- 244.92K
No earnings-call transcripts are available for IHE yet.
- Free Float
- —
- Shares Outstanding
- 11.32M
- Float Shares
- —
of shares held by institutions
215 13F filers
Congressional trading
Senate and House stock disclosures for IHE, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Fisher Asset Management, LLC | 2.70M | ▼ 28.42K |
| Foundations Investment Advisors, LLC | 982.20K | ▲ 978.17K |
| Morgan Stanley | 882.27K | ▲ 424.65K |
| Bank Of America Corp | 578.70K | ▼ 284.01K |
| Jpmorgan Chase & Co | 430.24K | ▼ 123.57K |
| Mml Investors Services, LLC | 418.06K | ▲ 408.85K |
| Td Asset Management Inc | 320.55K | ▲ 128.05K |
| Minichmacgregor Wealth Management, LLC | 319.31K | ▲ 319.31K |
| Lpl Financial LLC | 311.91K | ▲ 80.99K |
| Horizon Investments, LLC | 305.19K | ▲ 305.19K |
| Bank Of Montreal /Can/ | 282.80K | ▲ 274.98K |
| Aptus Capital Advisors, LLC | 277.21K | ▲ 277.21K |
Held by 2 ETFs
Biggest fund positions in IHE by dollar value.
Our IHE coverage
Recent articles, reports, and earnings notes.
No research on IHE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IHE report →IHE: 21% Next-Year EPS Growth Supports More Upside For U.S. Pharmaceuticals
seekingalpha.com · Nov 19
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
zacks.com · Nov 18
Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT?
fool.com · Nov 11
ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win
zacks.com · Nov 11
Pharmaceuticals ETF (IHE) Hits a New 52-Week High
zacks.com · Nov 11
Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors
fool.com · Nov 7
Capital Investment Advisors LLC Makes New $630,000 Investment in iShares U.S. Pharmaceuticals ETF $IHE
defenseworld.net · Oct 27
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
fool.com · Oct 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.